Fundación Fls De Lucha Contra El Sida, Las Enfermedades Infecciosas Y La Promoción De La Salud Y La Ciencia
Clinical trials sponsored by Fundación Fls De Lucha Contra El Sida, Las Enfermedades Infecciosas Y La Promoción De La Salud Y La Ciencia, explained in plain language.
-
Can a 10-day antiviral course protect kidney transplant patients from severe COVID?
Disease control Recruiting nowThis study tests whether giving the antiviral drug remdesivir for 10 days can prevent severe COVID-19 in kidney transplant recipients who have mild or no symptoms. About 15 adults will receive the drug starting just before their transplant. The goal is to see if this approach all…
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Could a cancer drug ease long COVID? new trial aims to find out
Symptom relief Recruiting nowThis study tests whether the drug plitidepsin can safely improve overall health in people with long COVID. About 90 adults with moderate-to-severe symptoms will receive either the drug or a placebo through an IV over four treatment cycles. Researchers will measure changes in heal…
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC